Research graph
References from Cross-clade protection against human H5N1 isolates by a clade 2.3.4.4b HA mRNA vaccine in mice. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Highly pathogenic avian influenza a(H5N1) virus infections in humans
10.1056/nejmoa2414610 · 2025 · External reference
Highly pathogenic avian influenza a(H5N1) virus infection in a dairy farm worker
10.1056/nejmc2405371 · 2024 · External reference
The global H5N1 influenza panzootic in mammals
10.1038/s41586-024-08054-z · 2025 · External reference
Unresolved reference
2026 · External reference
Efficacy and limitations of an improved vaccine derived from an updated vaccine strain against H5 highly pathogenic avian influenza
2026 · External reference
Resurgence of zoonotic highly pathogenic avian influenza a(H5N1) virus in Cambodia
10.1056/nejmc2504302 · 2025 · External reference
Unresolved reference
External reference
Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine
10.1056/nejmoa2034577 · 2020 · External reference
Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine
10.1056/nejmoa2035389 · 2021 · External reference
Unresolved reference
External reference
Low-inflammatory lipid nanoparticle-based mRNA vaccine elicits protective immunity against H5N1 influenza virus with reduced adverse reactions
10.1016/j.ymthe.2024.12.032 · 2025 · External reference
Molecular basis for high virulence of Hong Kong H5N1 influenza a viruses
10.1126/science.1062882 · 2001 · External reference
A single amino acid in the PB2 gene of influenza a virus is a determinant of host range
10.1128/jvi.67.4.1761-1764.1993 · 1993 · External reference
A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA
10.1016/j.omtn.2019.02.018 · 2019 · External reference
Self-degradable lipid-like materials based on “hydrolysis accelerated by the intra-particle enrichment of reactant (HyPER)” for messenger RNA delivery
10.1002/adfm.201910575 · 2020 · External reference
Characterization of a neutralizing antibody that recognizes a loop region adjacent to the receptor-binding interface of the SARS-CoV-2 spike receptor-binding domain
10.1128/spectrum.03655-23 · 2024 · External reference
Synergistic effect of non-neutralizing antibodies and interferon-γ for cross-protection against influenza
10.1016/j.isci.2021.103131 · 2021 · External reference
Immunological mechanisms of mRNA vaccines for infectious diseases
10.1038/s41586-026-10599-0 · 2026 · External reference
